Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

16 Sep 2021 07:00

RNS Number : 9195L
Income & Growth VCT (The) PLC
16 September 2021
 

 

The Income & Growth VCT plc

("the Company")

LEI: 213800FPC15FNM74YD92

 

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2021

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2021. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 June 2021

(unaudited)

At 31 March 2021

(unaudited)

Net assets attributable toshareholders

£120.31 million

£111.95 million

Shares in issue

117,734,097

118,200,511

Net asset value (NAV) per share

102.19 pence

94.71 pence

Cumulative dividends paid

131.50 pence

131.50 pence

Cumulative Total return (net asset value basis) per share since inception

233.69 pence

226.21 pence

The NAV per share has increased by 7.48 pence in the quarter (an increase of 7.9% upon the opening NAV per share). This positive performance is principally due to a continued rise in unrealised portfolio valuations.

 

 

Proposed change in management arrangements

As announced by the Company via RNS on 10 September 2021, Mobeus Equity Partners LLP (Mobeus), the investment adviser to the Company has announced the sale of its VCT fund and investment management business to a subsidiary of Gresham House plc (Gresham House). As part of the sale, the Board has agreed to the novation of the investment advisory arrangements from Mobeus to Gresham House subject to completion of the sale. Gresham House is a fast growing, specialist fund group, with a long-term commitment to the VCT industry and is the existing investment manager of the Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc (the Baronsmead VCTs). The entire core management, investment and operational teams involved with the Mobeus VCTs will all transfer to Gresham House in connection with this transaction to form a significantly enlarged team that will manage both the Mobeus VCTs and the Baronsmead VCTs. The Board can confirm that no material changes are being made to the terms of the investment advisory arrangements. Shareholders can also be assured that the Board's track record of governance and independence will be maintained.

 

 

INTERIM DIVIDEND

The Board declared an interim dividend of 5.00 pence per share for the year ending 30 September 2021. This dividend was paid to Shareholders on 23 July 2021 who were on the Register on 25 June 2021 and brings cumulative dividends paid per share to 136.50 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

 

SHARE BUY-BACKS

 

On 25 June 2021, the Company purchased 466,414 of its own ordinary shares at a price of 85.22 pence per share for cancellation.

 

 

DIVIDEND INVESTMENT SCHEME

 

After the period end, on 23 July 2021, the Company allotted 1,178,669 shares to participants of the Dividend Investment Scheme at a price of 89.71 pence per share, being the latest published NAV at 31 March 2021 of 94.71 pence per share adjusted for the 5.00 pence per share interim dividend. Following this allotment, the Company has 118,912,766 ordinary shares of 1 penny each in issue.

 

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New investments during the period

On 22 June 2021, a new investment of £0.91 million was made into Legatics, a SaaS LegalTech software business.

 

On 25 June 2021, a new investment of £0.84 million was made into Pets' Kitchen (trading as Vet's Klinic), a veterinary clinics business and pet food provider.

 

Follow-on investments during the period

On 16 April 2021 and 18 May 2021, follow-on investments totalling £0.25 million were made into Caledonian Leisure, a provider of UK leisure and experience breaks.

 

On 26 May 2021, a follow-on investment of £0.39 million was made into Bella & Duke, a premium frozen raw dog food provider.

 

On 27 June 2021, a follow-on investment of £0.08 million was made into Spanish Restaurant Group Limited (trading as Tapas Revolution), a Spanish restaurant chain.

Loan repayments during the period

On 1 April 2021, a loan repayment of £0.32 million was received by the Company from Vian Marketing Limited (trading as Red Paddle).

 

On 28 May 2021, a loan repayment of £0.46 million was received by the Company from MPB Group Limited.

 

 

Other proceeds received during the period.

 

On 12 April 2021, the Company received further proceeds of £0.04 million in respect of Vectair Holdings Limited, an investment realised in a previous year.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

Follow-on investments after the period end

On 5 August 2021, a follow-on investment of £0.95 million was made into MyTutor, a digital tutoring marketplace.

 

Partial realisation after the period end

On 6 August 2021, the Company sold part of its original equity holding in MyTutor to a large strategic investor generating proceeds of £0.95 million and a £0.70 million realised gain for the Company over the original cost of the equity shares sold. In isolation, the impact of this partial sale is a 0.10 pence uplift in NAV per share compared to the 30 June 2021 NAV per share of 102.19 pence, referred to above.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

 

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVUNRAWUKAAR
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20253:49 pmRNSDirector/PDMR Shareholding
11th Apr 20253:12 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
6th Mar 20251:23 pmRNSInterim Management Statement
5th Mar 20256:05 pmRNSResult of AGM
5th Mar 20255:17 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20256:10 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20257:00 amRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
29th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20243:10 pmRNSDirector/PDMR Shareholding
18th Oct 20242:58 pmRNSIssue of Equity and Total Voting Rights
17th Oct 20244:26 pmRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:05 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
26th Sep 20242:23 pmRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202410:00 amRNSOffer for Subscription – Update
12th Sep 20245:31 pmRNSInterim Management Statement
11th Sep 20244:33 pmRNSDividend Declaration
2nd Sep 20243:15 pmRNSOffers for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:30 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:35 amRNSTotal Voting Rights
27th Jun 20248:00 amRNSDirector Declaration
18th Jun 20245:54 pmRNSPROPOSED MERGER AND OFFERS
12th Jun 20244:08 pmRNSHalf-year Report
12th Jun 202410:39 amRNSIssue of Equity and Total Voting Rights
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
7th Jun 202411:05 amRNSDirector/PDMR Shareholding
7th Jun 202410:29 amRNSIssue of Equity and Total Voting Rights
3rd Jun 20242:29 pmRNSNet Asset Value at 31 March 2024
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.